Functional impact of IRF4 mutations on genomic binding in patient-derived B-EBV cells [ChIP-seq]
Ontology highlight
ABSTRACT: An IRF4 de novo mutation affecting the DNA binding domain of encoded IRF4 protein (mutDBD) was identified in a patient presenting with combined immunodeficiency. The patient exhibited profound susceptibility to opportunistic infections notably Pneumocystis jirovecii and humoral immunodeficiency caused by a failure of terminal B cell differentiation. A heterozygous IRF4 missense variant resulting in a phenylalanine-to-leucine replacement within the interferon activation domain of the encoded IRF4 protein (mutIAD) was identified in three patients from a multigenerational family suffering from a novel autosomal dominant disease predominantly presenting as a hypogammaglobulinemia with recurrent infections. In this experiment we aimed to investigate the effect of the two different mutations on IRF4 genomic binding.
ORGANISM(S): Homo sapiens
PROVIDER: GSE199684 | GEO | 2023/03/06
REPOSITORIES: GEO
ACCESS DATA